泰舆生物 (873592.OC)

+ 收藏

现金流量表(泰舆生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 5,487,822.9615,572,592.818,592,386.4314,048,730.337,124,200.72
 收到的税费返还(元) 18,681.15241.85--14,258.37
 收到其他与经营活动有关的现金(元) 52,877.526,558,664.36119,906.952,409,991.07650,392.77
 经营活动现金流入小计(元) 5,559,381.6322,131,499.028,712,293.3816,458,721.407,788,851.86
 购买商品、接受劳务支付的现金(元) 6,279,152.5512,834,913.735,714,837.0511,432,072.883,893,764.63
 支付给职工以及为职工支付的现金(元) 1,152,845.973,143,127.541,612,719.932,993,852.881,432,529.15
 支付的各项税费(元) 30,932.89218,064.31229,374.25165,823.4334,573.35
 支付其他与经营活动有关的现金(元) 775,518.187,918,554.63448,090.221,364,951.43261,118.97
 经营活动现金流出小计(元) 8,238,449.5924,114,660.218,005,021.4515,956,700.625,621,986.10
 经营活动产生的现金流量净额(元) -2,679,067.96-1,983,161.19707,271.93502,020.782,166,865.76
二、投资活动产生的现金流量
 收回投资收到的现金(元) 8,530,000.0017,660,000.007,190,000.0012,510,000.005,139,029.91
 取得投资收益收到的现金(元) 20,428.66313,303.35-1,579.83-
 投资活动现金流入小计(元) 8,550,428.6617,973,303.357,190,000.0012,511,579.835,139,029.91
 购建固定资产、无形资产和其他长期资产支付的现金(元) 7,035.4010,987.001,229,000.001,139,073.27-
 投资支付的现金(元) 5,100,000.0018,930,000.008,350,000.009,170,000.005,470,000.00
 投资活动现金流出小计(元) 5,107,035.4018,940,987.009,579,000.0010,309,073.275,470,000.00
 投资活动产生的现金流量净额(元) 3,443,393.26-967,683.65-2,389,000.002,202,506.56-330,970.09
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 2,400,000.003,980,000.001,300,000.00-400,000.00
 筹资活动现金流入小计(元) 2,400,000.003,980,000.001,300,000.00-400,000.00
 偿还债务支付的现金(元) 3,030,000.001,451,256.67-2,500,000.002,500,000.00
 分配股利、利润或偿付利息支付的现金(元) 10,222.63-3,585.8347,077.4947,220.00
 筹资活动现金流出小计(元) 3,040,222.631,451,256.673,585.832,547,077.492,547,220.00
 筹资活动产生的现金流量净额(元) -640,222.632,528,743.331,296,414.17-2,547,077.49-2,147,220.00
四、汇率变动对现金及现金等价物的影响(元) ----12,699.03-
五、现金及现金等价物净增加额(元) 124,102.67-422,101.51-385,313.90144,750.82-311,324.33
 加:期初现金及现金等价物余额(元) 284,030.66706,132.17946,132.17561,381.35561,381.35
 期末现金及现金等价物余额(元) 408,133.33284,030.66560,818.27706,132.17250,057.02
补充资料:
 净利润(元) -510,600.40650,908.23901,449.722,526,094.22850,223.11
 固定资产和投资性房地产折旧(元) 292,084.78534,686.93263,112.29509,177.91250,828.60
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 292,084.78534,686.93263,112.29509,177.91250,828.60
 无形资产摊销(元) ---18,199.1518,199.15
 长期待摊费用摊销(元) -60,666.7019,395.8133,249.9716,624.99
 财务费用(元) 10,222.6327,095.913,585.8359,991.7447,220.00
 投资损失(元) -20,428.66-313,303.35-5,025.00-1,579.83-1,579.83
 递延所得税(元) --57,182.67--3,218.1816,153.81
  其中:递延所得税资产减少(元) --57,182.67--3,218.1816,153.81
 存货的减少(元) -1,899,913.89165,923.47-1,395,810.85-642,347.421,739,912.55
 经营性应收项目的减少(元) -3,144,579.931,554,564.3324,644.30-4,266,009.06-889,823.39
 经营性应付项目的增加(元) 2,917,820.49-4,835,251.41988,413.272,196,718.63183,722.04
 现金的期末余额(元) 408,133.33284,030.66560,818.27706,132.17250,057.02
 减:现金的期初余额(元) 284,030.66706,132.17946,132.17561,381.35561,381.35
 现金及现金等价物的净增加额(元) 124,102.67-422,101.51-385,313.90144,750.82-311,324.33
公告日期 2024-08-152024-03-282023-08-152023-03-302022-08-10
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院